Morristown Medical Center and MoleSafe USA are pleased to announce the opening of the Skin Surveillance Program (SSP) at the Carol G. Simon Cancer Center. The opening of MoleSafe’s newest location provides the community with access to a novel type of diagnostic screening for the early detection of skin cancers, including melanoma.
“We recognize the critical importance that preventive care and early detection programs play in the health and well-being of our community,” says Eric Whitman, MD, medical director, Atlantic Health System Cancer Care. “The opening of MoleSafe’s newest location provides the residents of Morristown and surrounding communities access to this novel, high-technology skin diagnostic screening for the early detection of skin cancers – primarily melanoma,” adds Dr. Whitman, who is also director of the Atlantic Melanoma Center at Morristown Medical Center.
Melanoma is cancer that grows in the cells of the skin that produce melanin – the pigment that gives skin its color. Though there is no definitive cause, overexposure to ultraviolet (UV) rays from the sun or tanning beds drastically increases the risk.
Over the past three decades, more people have had skin cancer than all other cancers combined. In fact, it is estimated that 87,110 new cases of invasive melanoma will be diagnosed in the U.S. and 9,730 people will die of melanoma in 2017.